• Follow us
  • EN
    Flag Indonesia ID
    Flag English EN
Untitled design (6)
  • About Us
    • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Recruitment
  • PPID
  • Contact Us
search

Breaking the Chain of Rabies Transmission

Wednesday, 8 January 2025

Rabies remains a critical public health issue in over 150 countries, with Asia and Africa carrying the greatest burden. The disease causes tens of thousands of lives each year, with 40% of cases affecting children under 15. Caused by viruses in the genus Lyssavirus of the Rhabdoviridae family, this zoonotic viral disease is primarily transmitted through the saliva of infected animals, often via bites, scratches, or contact with mucosal surfaces such as the eyes, mouth, or open wounds. Once clinical symptoms appear, rabies is nearly always fatal.

Approximately 98% of human rabies cases occur in regions with large stray canine populations, though other animals, such as bats and foxes, also contribute to transmission. Following exposure, the incubation period typically ranges from several weeks to months. The virus travels through the peripheral nerves to the central nervous system, where it replicates and rapidly spreads to various tissues in the body.

Symptoms

The initial phase of rabies may begin months or even years after being infected with saliva from a rabid animal. The delay is due to the slow movement of the virus along the sensory nerves to the brain and spinal cord. Early symptoms are similar to those of less serious viral diseases, including weakness, headache, and loss of appetite.

1. Furious Rabies

    • Most rabies patients enter the "furious phase."
    • Marked by heightened sensitivity to stimuli and hydrophobia (fear of liquids).
    • Symptoms include:
      • Violent vomiting.
      • Audible screams during agitation.
      • Brief moments of calm lucidity.
    • The phase ends in a coma and death due to central nervous system failure.

2. Paralytic Rabies

    • Represents about 20% of rabies cases.
    • Progresses more slowly and subtly compared to the furious form.
    • It begins with paralysis at the wound site, which gradually spreads to other muscles.
    • Leads to the development of a coma and eventual death
Prevention

Implementing mass canine vaccination programs, including adult canines and puppies, has been identified as the most economically efficient method for rabies prevention in humans. This approach effectively interrupts transmission at its primary source.

Furthermore, immediate wound cleaning greatly decreases the risk of developing rabies. Recommended first aid for bite wounds and scratches includes thorough flushing with soap and water, povidone iodine, or other virucidal substances. Care should be taken to avoid contamination or enlargement of the wound. Rabies can be effectively prevented through vaccination. There are two main types of rabies vaccination: pre-exposure vaccination and post-exposure prophylaxis. 

Pre-exposure vaccination is recommended for people at continuous or increased risk of exposure to rabies, such as laboratory staff, veterinarians, and anyone who works with animals or wildlife. It is also a recommended prevention strategy for infants and children in areas with a high incidence of canine rabies, especially in areas with limited access to immediate care or rabies immunoglobulin. 

Post-exposure prophylaxis should be initiated as soon as rabies exposure is suspected, particularly after an unprovoked animal bite. If administered before the onset of clinical symptoms, it effectively prevents the virus from reaching the nervous system.

 

Source

World Health Organization. Rabies. 2024

World Health Organization. Human Rabies Prevention and Management. 2019

World Health Organization. Frequently Asked Questions about Rabies for the General Public 

Botting, J. H. (2015). Rabies. In R. M. Botting (Ed.), Animals and Medicine: The Contribution of Animal Experiments to the Control of Disease (1st ed., pp. 17–28). Open Book Publishers. http://www.jstor.org/stable/j.ctt15m7ng5.7

Crowcroft, N. S., & Thampi, N. (2015). The prevention and management of rabies. BMJ: British Medical Journal, 350. https://www.jstor.org/stable/26517874 

  • Share to:
Download

Latest News

Uterus illustration symbolizing cervical cancer prevention, early detection, and women’s health.
Friday, 19 December 2025
HPV Infection: Symptoms, Causes, and How to Prevent Cervical Cancer
Tangan lansia gemetar memegang tangan pendamping sebagai simbol dukungan dan perawatan bagi penderita penyakit Parkinson
Friday, 24 October 2025
Parkinson’s Disease Explained: Symptoms, Causes, and Effective Treatments
A young woman sitting on a sofa covered with a blanket, sneezing into a tissue due to flu or cold, illustrating symptoms of influenza and the importance of maintaining health and immunity
Tuesday, 21 October 2025
Understanding Influenza: Symptoms and Prevention
View more

Logo biofarma

Call Center 1500810

Head Office

Jl. Pasteur No. 28, Bandung 40161,
Jawa Barat Indonesia
+62 22-2033755
+62 22 - 2041306
mail@biofarma.co.id

Breeding Facility Bio Farma

Jl. Kolonel Masturi Kav 10. Desa Kertawangi kec. Cisarua
Jawa Barat

Bio Farma Representative Office

Gd. Pakarti centre Lantai 7
Jln. Tanah Abang 3 no.23-27
Jakarta Pusat

Information

  • Good Corporate Governance
  • Our Procurement
  • FAQ
  • Vaccine Production
  • Your Career

 

  • Contact Us
  • E-PPID
  • Announcement
  • Media Release

Quick Links

  • Portal BUMN-Bio
  • Kemenkes RI
Copyright © 2026. All Rights Reserved by Bio Farma

Change Language

EN
  • About Us
    • Company Profile
      • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Career
    • Recruitment
  • PPID
  • Contact Us
  • Follow us
Change Language
  • Flag Indonesia ID
  • Flag English EN